That’s what former FDA commissioner Dr. David Kessler said about the book, “Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care,” which listed as co-authors Drs. Charles B. Nemeroff and Alan F. Schatzberg.
But, as the New York Times reports, the “authors” acknowledged in the preface of the book they had received an “unrestricgted educational grant from a major drug company. The Times continues:
“But the drug maker, then known as SmithKline Beecham, actually had much more involvement than the book described, newly disclosed documents show. The grant paid for a writing company to develop the outline and text for the two named authors, the documents show, and then the writing company showed three drafts directly to the pharmaceutical company for comments and “sign-off” and showed page proofs for “final approval.”
“That doesn’t sound unrestricted to me,” Dr. Bernard Lo, a medical ethicist and chairman of an Institute of Medicine group that wrote a 2009 report on conflicts of interest, said after reviewing the documents. “That sounds like they have ultimate control.”